Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Sarepta Therapeutics (NQ: SRPT ) 113.33 -10.13 (-8.21%) Streaming Delayed Price Updated: 4:00 PM EDT, May 28, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Sarepta Therapeutics < Previous 1 2 ... 7 8 9 10 11 12 13 14 Next > 'Fast Money Halftime Report' Picks For August 24 August 24, 2021 On CNBC's "Fast Money Halftime Report," Stephanie Link said Aptiv PLC (NYSE: APTV) is worthy of a buy. Jon Najarian bought Sarepta Therapeutics Inc (NASDAQ: SRPT) on... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For August 5, 2021 August 05, 2021 Upgrades Stephens & Co. upgraded the previous rating for Roku Inc (NASDAQ: Via Benzinga Sarepta Therapeutics (SRPT) Q2 2021 Earnings Call Transcript August 05, 2021 SRPT earnings call for the period ending June 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial PreMarket Prep Recap: The 4 Stocks Dennis Dick Bought Yesterday June 24, 2021 On Wednesday’s PreMarket Prep, co-hosts Joel Elconin and Dennis Dick discussed the bullish chart setups in several tech stocks. ... Via Benzinga 99 Biggest Movers From Yesterday August 06, 2021 Gainers Score Media and Gaming Inc. (NASDAQ: SCR) shares climbed 79.9% to close at $32.64 on Thursday after the company, and Penn National Gaming, announced they entered into a... Via Benzinga The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal July 28, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Bio-Rad Laboratories, Inc... Via Benzinga Exposures COVID-19 Earnings Scheduled For May 5, 2021 May 05, 2021 Companies Reporting Before The Bell • Monmouth Real Estate (NYSE:MNR) is likely to report earnings for its second quarter. • EyePoint Pharmaceuticals (NASDAQ:EYPT... Via Benzinga Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge May 01, 2021 Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name... Via Benzinga Exposures Product Safety Earnings Scheduled For August 4, 2021 August 04, 2021 Companies Reporting Before The Bell • UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter. • Vericel (NASDAQ:VCEL) is expected to... Via Benzinga Stocks That Hit 52-Week Lows On Tuesday July 27, 2021 During Tuesday's morning session, 216 companies made new 52-week lows. Noteworthy Points: Alibaba Group Holding (NYSE:BABA) was the largest firm by market cap... Via Benzinga The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street July 20, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 19) Cytokinetics, Incorporated... Via Benzinga Stocks That Hit 52-Week Lows On Monday July 19, 2021 Stocks That Hit 52-Week Lows On Monday Monday morning, 285 companies reached new 52-week lows. Noteworthy Points: The largest company by market cap to set a new 52-week... Via Benzinga The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs July 15, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 14) Alexion Pharmaceuticals,... Via Benzinga Topics Product Recall Exposures Legal Product Safety Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2021 June 15, 2021 Upgrades According to Raymond James, the prior rating for Welltower Inc (NYSE:WELL) was changed from Market Perform to Strong Buy. For the first quarter, Welltower had an... Via Benzinga Sarepta's Stock Trading Higher As Duchenne Muscular Dystrophy Gene Therapy Shows Promise In Open-Label Study May 18, 2021 Sarepta Therapeutics Inc (NASDAQ: SRPT) has announced positive 12-week results from the first 11 participants enrolled in open-label study 9001-103 ENDEAVOR being... Via Benzinga Why Sarepta Might Have Just Reversed Its Fortunes In Gene Therapy May 18, 2021 Sarepta Therapeutics unveiled promising results Tuesday for a gene therapy that targets a muscle-wasting disease in children — and SRPT stock popped. Via Investor's Business Daily The Daily Biotech Pulse: Spero Secures NIAID Funding, GlaxoSmithKline Releases COVID-19 Data, BioNTech Gets New CFO May 18, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 17) Alexion Pharmaceuticals, Inc... Via Benzinga Exposures COVID-19 Why Sarepta's Q1 Results Won't Spark a Rebound for the Beaten-Down Biotech May 06, 2021 The company's revenue soared in Q1, but its bottom line still looked ugly. Via The Motley Fool Cathie Wood Buys $26M Disney Shares And Sells $13M In Netflix: What You Need To Know May 16, 2021 Cathie Wood-led Ark Investment Management on Friday bought 150,556 shares, worth about $26.15 million, in Walt Disney Co (NYSE: DIS), marking its debut in the media and... Via Benzinga Sarepta Therapeutics (SRPT) Q1 2021 Earnings Call Transcript May 06, 2021 SRPT earnings call for the period ending March 31, 2021. Via The Motley Fool Topics Earnings Exposures Financial Monthly Dosing Of Sarepta's Next-Gen Eteplirsen Can Potentially Achieve Over 10% Higher Dystrophin Expression In DMD Patients May 03, 2021 Sarepta Therapeutics Inc (NASDAQ: SRPT) announced positive results from Part A in a tiny group of 4 patients of the MOMENTUM Phase 2 study ... Via Benzinga Cathie Wood Sheds $33.6M Alibaba Shares On Earnings Day May 14, 2021 Cathie Wood-led Ark Investment Management on Thursday shed 162,840 shares, worth about $33.6 million, in Alibaba Group Holding (NYSE: BABA) after the company posted its first... Via Benzinga 3 Turnaround Stocks With 91% to 104% Upside, According to Wall Street April 30, 2021 Analysts believe these underperformers could nearly double over the next 12 months. Via The Motley Fool Topics Stocks Exposures US Equities Cathie Wood Piles Up Palantir For Third Day In A Row, Adding $39M Worth Of Shares May 12, 2021 Cathie Wood-led Ark Investment Management on Wednesday snapped up 2.07 million shares, worth about $39 million, in Palantir Technologies Inc (NYSE: PLTR), on a day the... Via Benzinga The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron May 12, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ... Via Benzinga Exposures COVID-19 Cathie Wood Loads Up $57M In Palantir As Stock Stages Reversal On Q1 Earnings Beat May 12, 2021 Cathie Wood-led Ark Investment Management on Tuesday snapped up 2.8 million shares, worth about $56.7 million, in Palantir Technologies Inc (NYSE: PLTR) after the data analytics... Via Benzinga Stocks That Hit 52-Week Lows On Tuesday May 11, 2021 Before 10 a.m. ET Tuesday, 173 stocks hit new 52-week lows. Intriguing Points: The largest company by market cap to set a new 52-week low was Snowflake (NYSE:SNOW... Via Benzinga Cathie Wood Cuts Apple Stake By 30% And Buys Coinbase, DraftKings May 10, 2021 Cathie Wood-led Ark Investment Management shed more shares of Apple Inc (NASDAQ: Via Benzinga Cathie Wood Slashes Apple Stake To Half — Also Trims Google, Fastly: What You Need To Know May 07, 2021 Cathie Wood-led Ark Investment Management nearly halved the Apple Inc (NASDAQ: AAPL) stake in the ARK Fintech Innovation ETF (NYSE: ARKF) on Thursday. ARKF shed 298,505 Apple... Via Benzinga The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues May 05, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)... Via Benzinga < Previous 1 2 ... 7 8 9 10 11 12 13 14 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.